Fatal breakthrough infection with Fusarium andiyazi: New multi-resistant aetiological agent cross-reacting with Aspergillus galactomannan enzyme immunoassay

Mycoses

Volumn 57, Issue 4, 2014, Pages 249-255

  Kebabci, Nesrin ^a   van Diepeningen, Anne D ^b   Ener, Beyza ^a   Ersal, Tuba ^a   Meijer, Martin ^b   Al Hatmi, Abdullah M S ^b   Özkocaman, Vildan ^a   Ursavaş, Ahmet ^a   Çetinoǧlu, Ezgi D ^a   Akalin, Halis ^a  

^a ULUDAG UNIVERSITY   (Turkey)

^b CBS KNAW FUNGAL BIODIVERSITY CENTRE   (Netherlands)

Author keywords

Acute leukaemia; Breakthrough infections; Fusarium andiyazi; Fusarium fujikuroi species complex; Galactomannan; Posaconazole prophylaxis

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANTINEOPLASTIC AGENT; CASPOFUNGIN; CEFOPERAZONE PLUS SULBACTAM; CLARITHROMYCIN; COTRIMOXAZOLE; FLUCONAZOLE; GALACTOMANNAN; INTERNAL TRANSCRIBED SPACER; ITRACONAZOLE; MICAFUNGIN; PIPERACILLIN PLUS TAZOBACTAM; POSACONAZOLE; TRANSCRIPTION ELONGATION FACTOR;

ACUTE GRANULOCYTIC LEUKEMIA; AGED; ALPHA CHAIN; ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; ASPERGILLUS; BLOOD CULTURE; CANCER CHEMOTHERAPY; CANCER REGRESSION; CASE REPORT; CHEMOPROPHYLAXIS; COMMUNITY ACQUIRED PNEUMONIA; COMPUTER ASSISTED TOMOGRAPHY; CROSS REACTION; DISEASE COURSE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ENZYME IMMUNOASSAY; FEVER; FUNGUS GROWTH; FUNGUS IDENTIFICATION; FUSARIOSIS; FUSARIUM; FUSARIUM ANDIYAZI; GENE SEQUENCE; HUMAN; INDUCTION CHEMOTHERAPY; MALE; MICROMORPHOLOGY; MULTILOCUS SEQUENCE TYPING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; THORAX RADIOGRAPHY; UNSPECIFIED SIDE EFFECT;

ACUTE LEUKAEMIA; BREAKTHROUGH INFECTIONS; FUSARIUM ANDIYAZI; FUSARIUM FUJIKUROI SPECIES COMPLEX; GALACTOMANNAN; POSACONAZOLE PROPHYLAXIS;

AGED; ANTIGENS, FUNGAL; ASPERGILLUS; CROSS REACTIONS; DIAGNOSIS, DIFFERENTIAL; DNA, FUNGAL; DNA, RIBOSOMAL SPACER; FUSARIOSIS; FUSARIUM; HUMANS; IMMUNOENZYME TECHNIQUES; LEUKEMIA, MYELOID, ACUTE; MALE; MANNANS; MULTILOCUS SEQUENCE TYPING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84895819003     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/myc.12142     Document Type: Article

References (35)

1. Reiss E, Shadomy HJ, Lyon GM (eds). Fundamental Medical Mycology. Hoboken, NJ: Wiley-Blackwell, 2012: 397-411.
2. Campo M, Lewis RE, Kontoyiannis DP. Invasive fusariosis in patients with hematologic malignancies at a cancer center. J Infect 2010; 60: 331-7.
3. Dignani MC, Anaissie E. Human fusariosis. Clin Microbiol Infect 2004; 10(Suppl. 1): S67-75.
4. Cornely OA, Maertens J, Winston DJ et al. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 2007; 356: 348-59.
5. Egerer G, Geist MJP. Posaconazole prophylaxis in patients with acute myelogenous leukaemia - results from an observational study. Mycoses 2011; 54(Suppl. 1): S7-11.
6. Boutati EI, Anaissie EJ. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years-experience at a cancer center and implications for management. Blood 1997; 90: 999-1008.
7. Lin SJ, Schranz J, Teutsch SM. Aspergillosis case-fatality rate: systematic review of the literature. Clin Infect Dis 2001; 32: 358-66.
8. Roden MM, Zaoutis TE, Buchanan WL et al. Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 2005; 41: 634-53.
9. Viscoli C, Girmenia C, Marinus A et al. Candidemia in cancer patients: a prospective, multicenter surveillance study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC). Clin Infect Dis 1999; 28: 1071-9.
10. de Pauw B, Walsh TJ, Donnell JP et al. Revised definitions of invasive fungal disease from the European Organization for Research and treatment of Cancer/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC/MSG) consensus group. Clin Infect Dis 2008; 46: 1813-21.
11. Pfeiffer CD, Fine JP, Safdar N. Diagnosis of invasive aspergillosis using a galactomannan assay: a meta analysis. Clin Infect Dis 2006; 42: 1417-27.
12. Kappe R, Schulze-Berge A. New cause of false positive results with the Pastorex Aspergillus antigen latex agglutination test. J Clin Microbiol 1993; 31: 2489-90.
13. Tortorano AM, Esposto MC, Prigitano A et al. Cross reactivity of Fusarium spp. in the Aspergillus Galactomannan enzyme-linked immunosorbent assay. J Clin Microbiol 2012; 50: 1051-3.
14. Mikulska M, Furfaro E, Bono VD et al. Galactomannan testing might be useful for early diagnosis of fusariosis. Diag Microbiol Infect Dis 2012; 72: 367-9.
15. Swanink CM, Meis JF, Rijs AJ, Donnelly JP, Verweij PE. Specificity of a sandwich enzyme-linked immunosorbent assay for detecting Aspergillus galactomannan. J Clin Microbiol 1997; 35: 257-60.
16. Cummings JR, Jamison GR, Boudreaux JW, Howles MJ, Walsh TJ, Hayden RT. Cross-reactivity of non-Aspergillus fungal species in the Aspergillus galactomannan enzyme immunoassay. Diag Microbiol Infect Dis 2007; 59: 113-5.
17. de Hoog GS, Guarro J, Gené J, Figueras MJ. Atlas of Clinical Fungi 3rd Ed., CD-ROM. Utrecht: CBS-KNAW Fungal Biodiversity Centre, 2011.
18. Nirenberg HI. Untersuchungen über die morphologische und biologische differenzierung in der Fusarium Sektion Liseola. Mitteilungen aus der Biologischen Bundesanstalt für Land- und Forstwirtschaft (Berlin - Dahlem) 1976; 169: 1-117.
19. Leslie JF, Summerell BA (eds). The Fusarium Laboratory Manual. Oxford: Blackwell Publishing Ltd, 2006.
20. Gerrits van den Ende AHG, de Hoog GS. Variability and molecular diagnostics of the neurotropic species Cladophialophora bantiana. Stud Mycol 1999; 43: 151-62.
21. O'Donnell K, Kistler HC, Cigelnik E, Ploetz RC. Multiple evolutionary origins of the fungus causing Panama disease of banana: concordant evidence from nuclear and mitochondrial gene genealogies. Proc Natl Acad Sci USA 1998; 95: 2044-9.
22. Benson DA, Cavanaugh M, Clark K et al. GenBank. Nucleic Acid Res 2013; 41: D36-42.
23. Geiser DM, Jiménez-Gasco M, Kang S et al. FUSARIUM-ID v. 1.0, A DNA sequence database for identifying Fusarium. Eur J Plant Pathol 2004; 110: 473-9.
24. O'Donnell K, Sutton DA, Rinaldi MG et al. Internet-accessible DNA sequence database for identifying fusaria from human and animal infections. J Clin Microbiol 2010; 48: 3708-18.
25. Ronquist FM, Teslenko P, van der Mark D et al. MrBayes 3.2: efficient Bayesian phylogenetic inference and model choice across a large model space. Syst Biol 2011; 61: 539-42.
26. Clinical and Laboratory Standards Institute. Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi. Approved standard, 2nd edn. Document M38-A2. Wayne, PA: Clinical and Laboratory Standards Institute, 2008.
27. Marasas WFO, Rheeder JP, Lamprecht SC, Zeller KA, Leslie JF. Fusarium andiyazi sp. nov., a new species from sorghum. Mycologia 2001; 93: 1203-10.
28. dal Prà M, Tonti S, Pancaldi D, Nipoti P, Alberti I. First report of Fusarium andiyazi associated with rice Bakanae in Italy. Plant Dis 2010; 94:1070.
29. Hsuan HM, Salleh B, Zakaria L. Molecular identification of Fusarium species in Gibberella fujikuroi species complex from rice, sugarcane and maize from Peninsular Malaysia. Int J Mol Sci 2011; 12: 6722-32.
30. Girmenia C, Frustaci AM, Gentile G et al. Posaconazole prophylaxis during front-line chemotherapy of acute myeloid leukemia: a single-center, real-life experience. Haemotologica 2012; 97: 560-7.
31. Lebeaux D, Lanternier F, Elie C et al. Therapeutic drug monitoring of posaconazole: a monocentric study with 54 adults. Antimicrob Agents Chemother 2009; 53: 5224-9.
32. Thompson GR, Rinaldi MG, Pennick G, Dorsey SA, Patterson TF, Lewis JS. Posaconazole therapeutic drug monitoring: a reference laboratory experience. Antimicrob Agents Chemother 2009; 53: 2223-4.
33. Cudillo L, Girmenia C, Santilli S et al. Breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis. Clin Infect Dis 2005; 40: 1212-3.
34. Kim MS, Sung HS, Won CH. Breakthrough disseminated fusariosis in an immunocompromised patient on voriconazole therapy. Int J Dermatol 2012; 51: 621-2.
35. Ferreira de Sousa I, Teixeira G, Abecasis M. Alternaria alternata infection in a patient with Fanconi's anemia after an unrelated bone marrow transplant. Clin Drug Invest 2013; 33(Suppl. 1):S33-S36.